CLINICAL ROLE -
Clinical Overview: Finerenone (Kerendia) Lowers Cardiovascular Events, Chronic Kidney Disease Progression
Finerenone is a first in class nonsteroidal mineralocorticoid receptor antagonist indicated in adults with chronic kidney disease associated with type 2 diabetes mellitus.
Read More